Mallinckrodt Plc Performance

MNKDelisted Stock  USD 0.46  0.02  4.17%   
The company secures a Beta (Market Risk) of 1.55, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Mallinckrodt Plc will likely underperform. Mallinckrodt Plc right now secures a risk of 0.0%. Please verify Mallinckrodt Plc treynor ratio and the relationship between the semi variance and price action indicator , to decide if Mallinckrodt Plc will be following its current price movements.

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Mallinckrodt Plc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent basic indicators, Mallinckrodt Plc is not utilizing all of its potentials. The latest stock price mess, may contribute to short-term losses for the institutional investors. ...more
Begin Period Cash Flow1.1 B
  

Mallinckrodt Plc Relative Risk vs. Return Landscape

If you would invest  46.00  in Mallinckrodt Plc on August 24, 2024 and sell it today you would earn a total of  0.00  from holding Mallinckrodt Plc or generate 0.0% return on investment over 90 days. Mallinckrodt Plc is generating negative expected returns assuming volatility of 0.0% on return distribution over 90 days investment horizon. In other words, 0% of stocks are less volatile than Mallinckrodt, and above 99% of all equities are expected to generate higher returns over the next 90 days.
  Expected Return   
       Risk  

Mallinckrodt Plc Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Mallinckrodt Plc's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Mallinckrodt Plc, and traders can use it to determine the average amount a Mallinckrodt Plc's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
MNK
Based on monthly moving average Mallinckrodt Plc is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Mallinckrodt Plc by adding Mallinckrodt Plc to a well-diversified portfolio.

Mallinckrodt Plc Fundamentals Growth

Mallinckrodt Stock prices reflect investors' perceptions of the future prospects and financial health of Mallinckrodt Plc, and Mallinckrodt Plc fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Mallinckrodt Stock performance.

About Mallinckrodt Plc Performance

By examining Mallinckrodt Plc's fundamental ratios, stakeholders can obtain critical insights into Mallinckrodt Plc's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Mallinckrodt Plc is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Mallinckrodt plc develops, manufactures, markets, and distributes specialty pharmaceutical products and therapies in the United States, Europe, the Middle East, Africa, and internationally. The company was founded in 1867 and is based in Dublin, Ireland. Mallinckrodt Plc operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on AMEX Exchange. It employs 2778 people.

Things to note about Mallinckrodt Plc performance evaluation

Checking the ongoing alerts about Mallinckrodt Plc for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Mallinckrodt Plc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Mallinckrodt Plc is not yet fully synchronised with the market data
Mallinckrodt Plc has some characteristics of a very speculative penny stock
Mallinckrodt Plc has a very high chance of going through financial distress in the upcoming years
The company reported the last year's revenue of 2.21 B. Reported Net Loss for the year was (717.4 M) with profit before taxes, overhead, and interest of 610 M.
Over 97.0% of the company shares are owned by institutional investors
Evaluating Mallinckrodt Plc's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Mallinckrodt Plc's stock performance include:
  • Analyzing Mallinckrodt Plc's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Mallinckrodt Plc's stock is overvalued or undervalued compared to its peers.
  • Examining Mallinckrodt Plc's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Mallinckrodt Plc's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Mallinckrodt Plc's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Mallinckrodt Plc's stock. These opinions can provide insight into Mallinckrodt Plc's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Mallinckrodt Plc's stock performance is not an exact science, and many factors can impact Mallinckrodt Plc's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Other Consideration for investing in Mallinckrodt Stock

If you are still planning to invest in Mallinckrodt Plc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Mallinckrodt Plc's history and understand the potential risks before investing.
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules